Understand where real-world evidence most effectively complements or substitutes traditional trial data, from post-market surveillance and label expansion to challenging areas such as rare disease ...
The chronic and acute pain clinical trial analysis report delivers important insights into ongoing research of 200+ pipeline chronic and acute pain drugs, clinical strategies, upcoming therapeutics, ...
CURE spoke with Dr. Robert Alter of John Theurer Cancer Center about the best time to explore clinical trials. For patients ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...
Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...
From projects examining healthcare initiative impacts to groundbreaking medical developments, the forum — which annually ...
Prospective FORESEE trial of CNSide Cerebrospinal Fluid (CSF) Assay met key primary and secondary endpoints CNSide CSF Assay influenced clinical management decisions in over 90% of leptomeningeal ...
The drug is currently classified as a Schedule I controlled substance in the United States, leading those seeking treatment ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst research report was published on the Company that explains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results